Integrated modeling for drug development

Optimized strategy, from drug candidate to patient proof of concept

Physiologically-Based Pharmacokinetic modeling

For a better translation from non-clinical to human studies

Population Pharmacokinetics

To quantify and identify the source of variability in a population

Pharmacokinetics NCA

A comprehensive study of the Pharmacokinetics (PK) of your drug candidate

QT / QTc Analysis

A pioneer in exploring cardiac safety in early phase

Integrated Phase 1 Solutions

Tailored solutions to fast-track your biotech Phase 1 trials